Zhengye Biotechnology Holding Ltd dividend history

Zhengye Biotechnology Holding Ltd paid $2.2m in dividends in fiscal 2024. That was 141.7% of net income.

Dividends, buybacks and capital spending

Dividends (TTM): $2.2M
Returned to shareholders: 58%; of free cash flow
Diluted share count: +3.7%; year over year
Total shareholder yield: 3.5%; dividends 3.5% + buybacks 0.0% of market value
R&D spending: 15.5%; of revenue
Days sales outstanding: 60 days; receivables vs revenue

Dividends by fiscal year

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Zhengye Biotechnology Holding Ltd: dividends by fiscal year, annual
Fiscal year	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Dividends paid	3,190	5,575	2,227	—
Dividends ÷ net income	45.8%	125.4%	141.7%	—
Dividends ÷ free cash flow	—	96.7%	58.4%	—

Dividend per share is the amount declared for the fiscal year as stated in the company's filings (including any special dividend), restated for stock splits and checked against the cash dividends paid. Dividends paid and buybacks are cash amounts; the last-twelve-months column can include an extra payment when a quarter-end date moves.

Compare with peers

Scilex Holding Co dividends

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Zhengye Biotechnology Holding Ltd's SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Zhengye Biotechnology Holding Ltd.